PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27554814-0	2016	Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children.	ruxolitinib	43-54	stimulator of interferon response cGAMP interactor 1	Homo sapiens	104-111